Sibeprenlimab (Anti-TNFSF13 / APRIL / CD256)

Sibeprenlimab (Anti-TNFSF13 / APRIL / CD256) is a fully humanized IgG2κ monoclonal antibody that targets the B-cell growth factor APRIL (TNFSF13), with the potential to treat IgA nephropathy (IgAN). MW : 145.5 KD.

Price Not Available 1mg Sibeprenlimab (Anti-TNFSF13 / APRIL / CD256) Supplier Page

Trivial name	VIS649
Catalog Number	A2317
CAS#	2382896-07-1
Size	1mg
Supplier Page	http://www.selleckchem.com/products/sibeprenlimab-anti-tnfsf13-april-cd256.html